E-cigarettes: further flavours of controversy within the controversy by Bareham, David et al.
Spotlight
www.thelancet.com/respiratory   Published online December 1, 2017   http://dx.doi.org/10.1016/S2213-2600(17)30467-8 1
E-cigarettes: further f﻿lavours of controversy within the 
controversy
Although some observers have alluded to an emerging 
public health consensus in the UK regarding the potential 
for e-cigarettes to reduce tobacco-related harms, 
controversy emerged when major UK public health 
organisations seemed to send out conflicting messages 
regarding the devices. The Royal College of Physicians (RCP) 
in February, 2016, advocated that it was important to 
promote e-cigarettes “as widely as possible as a substitute 
for smoking in the UK”. However, the National Institute for 
Health and Clinical Excellence, in draft guidance published 
in September, 2017, suggested clinicians should advise that, 
although some smokers have found e-cigarettes helpful 
to quit smoking, “there is currently little evidence on the 
long-term benefits or harms of these products”. Several 
media outlets recognised the contrasting interpretations 
of the current evidence base. In October, 2017, member 
of parliament (MP) Norman Lamb, Chair of the UK 
Parliamentary Science and Technology Committee, said 
regarding e-cigarettes that “there are still significant gaps 
in the research guiding their regulation and sale”.
Further ongoing controversies have involved the UK 
All Party Parliamentary Group (APPG) for e-cigarettes and 
their interactions with the tobacco industry. The WHO 
Framework Convention on Tobacco Control Article 5.3, 
to which the UK is a signatory, advises that politicians do 
not interact unnecessarily with the tobacco industry, 
subsequent to the industry withholding scientific 
knowledge about the harms of smoking tobacco over 
several decades. Therefore the revelation that the Chair 
of the APPG for e-cigarettes, MP for Rugby Mark Pawsey, 
accepted approximately £1650 of hospitality from Japanese 
Tobacco International, owners of the e-cigarette brand 
E-Lites, provoked controversy. According to the Register 
of Member’s Financial Interests, Pawsey accepted the 
hospitality in October, 2015. In December, 2016, the British 
Medical Association (BMA) questioned the propriety 
of the same APPG receiving secretariat support worth 
£18 500 from the UK Vaping Industry Association (UKVIA). 
The UKVIA represent the interests, among others, of the 
tobacco companies, Philip Morris, British American Tobacco, 
Imperial Brands, and Japanese Tobacco International. This 
further unnecessary interaction with the tobacco industry 
is contrary to the spirit of Article 5.3 of the Framework 
Convention on Tobacco Control. The BMA described the 
support as an unhealthy influence of the tobacco industry 
over this parliamentary group.
The 2016 National Smoking Cessation and Training 
Centre (NCSCT) updated guidelines for e-cigarettes 
underline that, although the flavourings used in e-cigarette 
fluids are normally considered safe for oral ingestion, the 
effects of their long-term inhalation are largely unknown. 
The NCSCT advise that “There are some flavours where 
a degree of risk is established and so these flavours 
should be avoided”; these include cinnamon flavourings. 
Dr Rachel Behar (University of California, Berkley, CA, USA) 
and colleagues, first showed the potential for cinnamon 
flavoured e-cigarette fluids to be cytotoxic in March, 2014.
New data published in January, 2017, relating to a 
potential increased risk of male infertility from exposure to 
cinnamon e-cigarette fluids was met with skepticism from 
Professor Peter Hajek (Wolfson Institute of Preventative 
Medicine, Queen Mary University of London, London, UK) 
who stated that “There are no known adverse effects on 
fertility from exposure to cinnamon apple pies or chewing 
gum…the most likely impact of misinforming smokers 
about risks of vaping is that they carry on smoking.”
In March, 2017, allegations of irresponsible marketing 
tactics by elements of the e-cigarette industry were made 
by Dr Konstantinos Farsalinos, who stated in his blog 
“I wonder if there is anyone who thinks that the use of 
cartoons and funny graphics…is not going to be perceived 
as appealing, and an attempt to actively promote the 
products, to youth…this is absolutely unacceptable and a 
clear indication of irresponsible behaviour”.
Data from the US Centres for Disease Control and 
Prevention suggested that the number of high school 
students in the USA who were current users of e-cigarettes 
rose from 2·46 million in 2014 to 3 million in 2015. 
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For more on mixed messaging 
in the UK regarding e-cigarettes 
see http://www.bmj.com/
content/358/bmj.j4460
For the WHO FCTC Guidelines 
see http://www.who.int/fctc/
guidelines/article_5_3.pdf
For more on Mark Pawsey’s 
receipt of hospitality see http://
www.mirror.co.uk/news/uk-
news/tory-mp-heaps-
praise-e-7023311
For more on UKVIA’s support 
for the APPG for e-cigarettes 
see http://www.bma.org.uk/
news/2016/november/an-
unhealthy-interest-in-e-
cigarettes
For the NCSCT Guidelines see 
http://www.ncsct.co.uk/
publication_electronic_cigarette_
briefing.php
For more on the harms of 
cinnamon e-liquid flavourings 
see Toxicology in Vitro 2014; 
28: 198-208
For Professor Hajek’s comments 
on cinnamon flavourings see 
http://ash.org.uk/media-and-
news/ash-daily-news/ash-daily-
news-for-09-january-2017/
For more on Dr Farsalinos’ 
allegations see http://
www.ecigarette-research.org/
research/index.php/whats-
new/2017/251-indus
For the CDC data on e-cigarette 
use see https://www.cdc.gov/
tobacco/infographics/youth/
pdfs/youth-tobacco-use.pdf?s_
cid=bb-osh-youth-graphic-008
For the US Surgeon General’s 
report see https://e-cigarettes.
surgeongeneral.gov/
documents/2016_sgr_full_
report_non-508.pdf
For Bauld and colleagues’ 
comments see https://www.gov.
uk/government/uploads/system/
uploads/attachment_data/
file/311491/Ecigarette_uptake_
and_marketing.pdf
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In December, 2016, the US Surgeon General published 
a report stating that “E-cigarette use among youth and 
young adults has become a public health concern.”
Continued controversy surrounds the uptake of vaping 
in those children who are deemed unlikely to ever smoke 
cigarettes. In 2014, Professor Linda Bauld (University of 
Stirling, Stirling, UK) and colleagues, writing in a Public 
Health England document, stated that there was no 
evidence at the time to suggest that non-smoking children 
were taking up vaping, but that “longitudinal research will 
be required” to confirm this. Although subsequent data 
suggested that the proportion of never-smoking youth 
who have ever used an e-cigarette is increasing in the 
UK, Bauld and colleagues in August, 2017, claimed that 
there was still no evidence to suggest a gateway from 
e-cigarettes to smoking cigarettes in UK youth; however, 
the five surveys that were used to make this conclusion 
were not longitudinal. Meanwhile, a longitudinal study by 
Professor Mark Conner and colleagues (University of Leeds, 
Leeds, UK) also published in August 2017, found that “Ever 
use of e-cigarettes was robustly associated with initiation 
but more modestly related to escalation of cigarette use.” 
This added further supportive data to a systematic review 
and meta-analysis of longitudinal studies, also published in 
August, 2017, which showed a lack of overall consensus in 
the UK relating to this issue.
A 2017 Royal Society for Public Health undercover 
investigation identified that nine out of ten e-cigarette 
shops in the UK are selling products to adults who have 
never smoked or vaped. The Independent British Vape 
Trade Association inform sellers in their Code of Conduct 
that “Vape products are for current or former smokers and 
existing users of vaping devices, therefore never knowingly 
sell to anyone who is not a current or former smoker, 
or a current vaper.” Considering e-cigarette’s addictive 
potential, the scant evidence-base relating to their efficacy 
as quitting aids, and their potential for adverse health 
effects, reckless and irresponsible sales tactics used by 
e-cigarette outlets will continue to stimulate calls from 
many in public health, research, and academia for a 
precautionary perspective to be applied to e-cigarettes.
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never-smoking children who 
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